|
1
|
Carlson LM and Vora NL: Prenatal
diagnosis: Screening and diagnostic tools. Obstet Gynecol Clin
North Am. 44:245–256. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
mLevy B and Stosic M: Traditional prenatal
diagnosis: Past to present. Methods Mol Biol. 1885:3–22.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Carbone L, Cariati F, Sarno L, Conforti A,
Bagnulo F, Strina I, Pastore L, Maruotti GM and Alviggi C:
Non-invasive prenatal testing: Current perspectives and future
challenges. Genes (Basel). 12(15)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sifakis S, Papantoniou N, Kappou D and
Antsaklis A: Noninvasive prenatal diagnosis of Down syndrome:
Current knowledge and novel insights. J Perinat Med. 40:319–327.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lo YD, Corbetta N, Chamberlain PF, Rai V,
Sargent IL, Redman CW and Wainscoat JS: Presence of fetal DNA in
maternal plasma and serum. Lancet. 350:485–487. 1997.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lo YD, Zhang J, Leung TN, Lau TK, Chang AM
and Hjelm NM: Rapid clearance of fetal DNA from maternal plasma. Am
J Hum Genet. 64:218–224. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Fan HC, Blumenfeld YJ, Chitkara U, Hudgins
L and Quake SR: Noninvasive diagnosis of fetal aneuploidy by
shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA.
105:16266–16271. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sifakis S, Zaravinos A, Maiz N, Spandidos
DA and Nicolaides KH: First-trimester maternal plasma cell-free
fetal DNA and preeclampsia. Am J Obstet Gynecol. 201:472.e1–e7.
2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sifakis S, Koukou Z and Spandidos DA:
Cell-free fetal DNA and pregnancy-related complications (review).
Mol Med Rep. 11:2367–2372. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liehr T, Harutyunyan T, Williams H and
Weise A: Non-invasive prenatal testing in Germany. Diagnostics
(Basel). 12(2816)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jakobsen TR, Clausen FB, Rode L, Dziegiel
MH and Tabor A: High levels of fetal DNA are associated with
increased risk of spontaneous preterm delivery. Prenat Diagn.
32:840–845. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
van Boeckel SR, Davidson DJ, Norman JE and
Stock SJ: Cell-free fetal DNA and spontaneous preterm birth.
Reproduction. 155:R137–R145. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sugito Y, Sekizawa A, Farina A, Yukimoto
Y, Saito H, Iwasaki M, Rizzo N and Okai T: Relationship between
severity of hyperemesis gravidarum and fetal DNA concentration in
maternal plasma. Clin Chem. 49:1667–1669. 2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alberry MS, Maddocks DG, Hadi MA, Metawi
H, Hunt LP, Abdel-Fattah SA, Avent ND and Soothill PW:
Quantification of cell free fetal DNA in maternal plasma in normal
pregnancies and in pregnancies with placental dysfunction. Am J
Obstet Gynecol. 200:98.e91–e6. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jimbo M, Sekizawa A, Sugito Y, Matsuoka R,
Ichizuka K, Saito H and Okai T: Placenta increta: Postpartum
monitoring of plasma cell-free fetal DNA. Clin Chem. 49:1540–1541.
2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Seval MM, Karabulut HG, Tükün A and Koç A:
Cell free fetal DNA in the plasma of pregnant women with
preeclampsia. Clin Exp Obstet Gynecol. 42:787–791. 2025.PubMed/NCBI
|
|
17
|
Yin A, Ng EH, Zhang X, He Y, Wu J and
Leung KY: Correlation of maternal plasma total cell-free DNA and
fetal DNA levels with short term outcome of first-trimester vaginal
bleeding. Hum Reprod. 22:1736–1743. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sapantzoglou I, Gallardo Arozena M, Dragoi
V, Akolekar R, Nicolaides KH and Syngelaki A: Fetal fraction of
cell free DNA in screening for hypertensive disorders at 11-13
weeks. J Matern Fetal Neonatal Med. 35:5363–5368. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wataganara T, Chen AY, LeShane ES,
Sullivan LM, Borgatta L, Bianchi DW and Johnson KL: Cell-free fetal
DNA levels in maternal plasma after elective first-trimester
termination of pregnancy. Fertil Steril. 81:638–644.
2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wu Y, Werlang A, Cheng W, Lanes A, Wen SW
and Walker M: Association between levels of total cell-free DNA and
development of preeclampsia-A literature review. AJP Rep.
11:e38–e48. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Desoye G, Gauster M and Wadsack C:
Placental transport in pregnancy pathologies. Am J Clin Nutr. 94 (6
Suppl):1896S–1902S. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lazar L, Rigó J Jr, Nagy B, Balogh K, Makó
V, Cervenak L, Mézes M, Prohászka Z and Molvarec A: Relationship of
circulating cell-free DNA levels to cell-free fetal DNA levels,
clinical characteristics and laboratory parameters in preeclampsia.
BMC Med Genet. 10(120)2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kolarova TR, Gammill HS, Nelson JL,
Lockwood CM and Shree R: At preeclampsia diagnosis, total cell-free
DNA concentration is elevated and correlates with disease severity.
J Am Heart Assoc. 10(e021477)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Merriel A, Alberry M and Abdel-Fattah S:
Implications of non-invasive prenatal testing for identifying and
managing high-risk pregnancies. Eur J Obstet Gynecol Reprod Biol.
256:32–39. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Samango-Sprouse C, Banjevic M, Ryan A,
Sigurjonsson S, Zimmermann B, Hill M, Hall MP, Westemeyer M,
Saucier J, Demko Z and Rabinowitz M: SNP-based non-invasive
prenatal testing detects sex chromosome aneuploidies with high
accuracy. Prenat Diagn. 33:643–649. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Zimmermann B, Hill M, Gemelos G, Demko Z,
Banjevic M, Baner J, Ryan A, Sigurjonsson S, Chopra N, Dodd M, et
al: Noninvasive prenatal aneuploidy testing of chromosomes 13, 18,
21, X, and Y, using targeted sequencing of polymorphic loci. Prenat
Diagn. 32:1233–1241. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Ryan A, Hunkapiller N, Banjevic M,
Vankayalapati N, Fong N, Jinnett KN, Demko Z, Zimmermann B,
Sigurjonsson S, Gross SJ and Hill M: Validation of an enhanced
version of a SNP-Based noninvasive prenatal test for detection of
fetal chromosomal aneuploidies. Fetal Diagn Ther. 40:219–223.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wald NJ, Cuckle H, Brock JH, Peto R,
Polani PE and Woodford FP: Maternal serum-alpha-fetoprotein
measurement in antenatal screening for anencephaly and spina bifida
in early pregnancy. Report of UK collaborative study on
alpha-fetoprotein in relation to neural-tube defects. Lancet.
1:1323–1332. 1977.PubMed/NCBI
|
|
29
|
Bishop JC, Dunstan FD, Nix BJ, Reynolds TM
and Swift A: All MoMs are not equal: Some statistical properties
associated with reporting results in the form of multiples of the
median. Am J Hum Genet. 52:425–430. 1993.PubMed/NCBI
|
|
30
|
Clausen FB: Cell-free fetal DNA and fetal
blood group genotyping: Non-invasive prenatal testing. ISBT Science
Series. 15:46–51. 2020.
|
|
31
|
Breveglieri G, D'Aversa E, Finotti A and
Borgatti M: Non-invasive prenatal testing using fetal DNA. Mol
Diagn Ther. 23:291–299. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Fiorentino F, Bono S, Pizzuti F, Duca S,
Polverari A, Faieta M, Baldi M, Diano L and Spinella F: The
clinical utility of genome-wide non invasive prenatal screening.
Prenat Diagn. 37:593–601. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
van der Schoot CE, Winkelhorst D and
Clausen FB: Noninvasive fetal blood group typing. In: Noninvasive
Prenatal Testing (NIPT). Elsevier, pp125-156, 2018.
|
|
34
|
Radoi VE, Bohiltea CL, Bohiltea RE and
Albu DN: Cell free fetal DNA testing in maternal blood of Romanian
pregnant women. Iran J Reprod Med. 13:623–626. 2015.PubMed/NCBI
|
|
35
|
Liehr T: False-positives and
false-negatives in non-invasive prenatal testing (NIPT): What can
we learn from a meta-analyses on >750,000 tests? Mol Cytogenet.
15(36)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Antoniou E, Orovou E, Sarella A, Iliadou
M, Palaska E, Sarantaki A, Iatrakis G and Dagla M: Is primary
cesarean section a cause of increasing cesarean section rates in
greece? Mater Sociomed. 32:287–293. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
World Health Organization (WHO): Caesarean
section rates continue to rise, amid growing inequalities in
access. WHO, Geneva, 2021. https://www.who.int/news/item/16-06-2021-caesarean-section-rates-continue-to-rise-amid-growing-inequalities-in-access.
Accessed June 16, 2021.
|
|
38
|
Yaron Y, Heifetz S, Ochshorn Y, Lehavi O
and Orr-Urtreger A: Decreased first trimester PAPP-A is a predictor
of adverse pregnancy outcome. Prenat Diagn. 22:778–782.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
39
|
Cowans NJ, Stamatopoulou A, Maiz N,
Spencer K and Nicolaides KH: The impact of fetal gender on first
trimester nuchal translucency and maternal serum free β-hCG and
PAPP-A MoM in normal and trisomy 21 pregnancies. Prenat Diagn.
29:578–581. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
40
|
Lee LC, Sheu BC, Shau WY, Liu DM, Lai TJ,
Lee YH and Huang SC: Mid-trimester β-hCG levels incorporated in a
multifactorial model for the prediction of severe pre-eclampsia.
Prenat Diagn. 20:738–743. 2000.PubMed/NCBI View Article : Google Scholar
|
|
41
|
D'Antonio F, Rijo C, Thilaganathan B,
Akolekar R, Khalil A, Papageourgiou A and Bhide A: Association
between first-trimester maternal serum pregnancy-associated plasma
protein-A and obstetric complications. Prenat Diagn. 33:839–847.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
42
|
Nicolaides KH: Nuchal translucency and
other first-trimester sonographic markers of chromosomal
abnormalities. Am J Obstet Gynecol. 191:45–67. 2004.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Nicolaides KH, Azar G, Byrne D, Mansur C
and Marks K: Fetal nuchal translucency: Ultrasound screening for
chromosomal defects in first trimester of pregnancy. BMJ.
304:867–869. 1992.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Baer RJ, Norton ME, Shaw GM, Flessel MC,
Goldman S, Currier RJ and Jelliffe-Pawlowski LL: Risk of selected
structural abnormalities in infants after increased nuchal
translucency measurement. Am J Obstet Gynecol. 211:675.e1–19.
2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sekizawa A, Jimbo M, Saito H, Iwasaki M,
Matsuoka R, Okai T and Farina A: Cell-free fetal DNA in the plasma
of pregnant women with severe fetal growth restriction. Am J Obstet
Gynecol. 188:480–484. 2003.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Smid M, Galbiati S, Lojacono A, Valsecchi
L, Platto C, Cavoretto P, Calza S, Ferrari A, Ferrari M and
Cremonesi L: Correlation of fetal DNA levels in maternal plasma
with Doppler status in pathological pregnancies. Prenat Diagn.
26:785–790. 2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Al Nakib M, Desbriere R, Bonello N,
Bretelle F, Boubli L, Gabert J and Levy-Mozziconacci A: Total and
fetal cell-free DNA analysis in maternal blood as markers of
placental insufficiency in intrauterine growth restriction. Fetal
Diagn Ther. 26:24–28. 2009.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Thurik FF, Lamain-de Ruiter M, Javadi A,
Kwee A, Woortmeijer H, Page-Christiaens GC, Franx A, van der Schoot
CE and Koster MP: Absolute first trimester cell-free DNA levels and
their associations with adverse pregnancy outcomes. Prenat Diagn.
36:1104–1111. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Birch L, English CA, O'Donoghue K, Barigye
O, Fisk NM and Keer JT: Accurate and robust quantification of
circulating fetal and total DNA in maternal plasma from 5 to 41
weeks of gestation. Clin Chem. 51:312–320. 2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Jung K, Fleischhacker M and Rabien A:
Cell-free DNA in the blood as a solid tumor biomarker-a critical
appraisal of the literature. Clin Chim Acta. 411:1611–1624.
2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Fernando MR, Chen K, Norton S,
Krzyzanowski G, Bourne D, Hunsley B, Ryan WL and Bassett C: A new
methodology to preserve the original proportion and integrity of
cell-free fetal DNA in maternal plasma during sample processing and
storage. Prenat Diagn. 30:418–424. 2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Manokhina I, Singh TK, Peñaherrera MS and
Robinson WP: Quantification of cell-free DNA in normal and
complicated pregnancies: Overcoming biological and technical
issues. PLoS One. 9(e101500)2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Contro E, Bernabini D and Farina A:
Cell-Free Fetal DNA for the prediction of pre-eclampsia at the
first and second trimesters: A systematic review and meta-analysis.
Mol Diagn Ther. 21:125–135. 2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Sarzynska-Nowacka U, Kosinski P and
Wielgos M: Is there a future for cell-free fetal dna tests in
screening for preeclampsia? Ginekol Pol. 90:55–60. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Poon LC, Musci T, Song K, Syngelaki A and
Nicolaides KH: Maternal plasma cell-free fetal and maternal DNA at
11-13 weeks' gestation: Relation to fetal and maternal
characteristics and pregnancy outcomes. Fetal Diagn Ther.
33:215–223. 2013.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Rolnik DL, da Silva Costa F, Lee TJ,
Schmid M and McLennan AC: Association between fetal fraction on
cell-free DNA testing and first-trimester markers for
pre-eclampsia. Ultrasound Obstet Gynecol. 52:722–727.
2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Quezada MS, Francisco C, Dumitrascu-Biris
D, Nicolaides KH and Poon LC: Fetal fraction of cell-free DNA in
maternal plasma in the prediction of spontaneous preterm delivery.
Ultrasound Obstet Gynecol. 45:101–105. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Ridnõi K, Muru K, Keernik M, Pajusalu S,
Ustav EL, Tammur P, Mölter-Väär T, Kahre T, Šamarina U, Asser K, et
al: A two-year prospective study assessing the performance of fetal
chromosomal microarray analysis and next-generation sequencing in
high-risk pregnancies. Mol Genet Genomic Med.
9(e1787)2021.PubMed/NCBI View Article : Google Scholar
|
